XELLERA THERAPEUTICS
Xellera Therapeutics is a biotechnology company discovers and develops therapeutic and regenerative medicine for the treatment of diseases, trauma, and aging.
XELLERA THERAPEUTICS
Industry:
Biotechnology Pharmaceutical
Founded:
2018-01-01
Address:
Hong Kong, Hong Kong Island, Hong Kong
Country:
Hong Kong
Website Url:
http://www.xelleratherapeutics.com
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Official Site Inspections
http://www.xelleratherapeutics.com
- Host name: 172.67.162.45
- IP address: 172.67.162.45
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Xellera Therapeutics"
Our mission, management team & partners | Xellera Therapeutics
Xellera Therapeutics designs, develops, manufactures, and distributes high quality products for research and therapeutics. We are committed to meeting our clientsโ needs by providing the โฆSee details»
Xellera Therapeutics - Crunchbase Company Profile & Funding
Xellera Therapeutics is a biotechnology company discovers and develops therapeutic and regenerative medicine for the treatment of diseases, trauma, and aging.See details»
Our Team - Xellera Therapeutics Asia Limited
[management name=โMr. Allen Maโ position=โCo-chairโ description=โ Former CEO of Hong Kong Science & Technology Parks; President for APAC at British TelecomSee details»
Xellera Therapeutics - The Org
Xellera Therapeutics is a biotechnology company discovers and develops therapeutic and regenerative medicine for the treatment of diseases, trauma, and aging.See details»
Xellera Therapeutics Company Profile | Management and
Xellera Therapeutics Profile and History. Xellera Therapeutics Limited (XT) is dedicated to developing cell- and gene-based therapies. XTโs mission is to bring advanced therapeutic โฆSee details»
Xellera Therapeutics - LinkedIn
Xellera Therapeutics | 230 followers on LinkedIn. Our mission is to bring advanced therapeutic options to patients in an era of precision medicine. | Founded in 2018, Xellera operates Hong โฆSee details»
Xellera Therapeutics - VentureRadar
Founded in 2018, Xellera Therapeutics (โXelleraโ), operates Hong Kongโs FIRST commercial current Good Manufacturing Practice (cGMP) facilities for... ... Find ...See details»
XELLERA THERAPEUTICS LIMITED - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for XELLERA THERAPEUTICS LIMITED of Kwun Tong. Get the latest business insights from Dun & โฆSee details»
Xellera Therapeutics Ltd:Company Profile & Technical Research ...
Xellera Therapeutics is a company that provides Stem cell, Stem cell line, Immunosuppression and more. Xellera Therapeutics is headquartered in Hong Kong Hong Kong Island.See details»
Xellera Therapeutics Ltd: Drug pipelines, Patents, Clinical trials ...
Aug 17, 2023 Explore Xellera Therapeutics Ltd with its drug pipeline, therapeutic area, technology platform, .See details»
Corporate Responsibility and Ethics | Xellera Therapeutics
Corporate Governance and Ethics: We are dedicated to upholding the highest standards of corporate governance and ethical conduct. The companyโs decision-making and actions are โฆSee details»
Xellera Therapeutics - Overview, News & Similar companies
Who is Xellera Therapeutics. Xellera Therapeutics Limited (XT) is dedicated to developing cell- and gene-based therapies. XTโs mission is to bring advanced therapeutic options to patients in โฆSee details»
Xellera Therapeutics Ltd. - BioCentury Company Profiles - BCIQ
Xellera Therapeutics Ltd. - BioCentury Company Profiles for the biopharma industrySee details»
Xellera Therapeutics - Products, Competitors, Financials, โฆ
Producing cancer therapy cells in Hong Kong to lower treatment cost for leukaemia patients, Hong Kong biotechnology company says. Oct 10, 2023. South China Morning Post Xellera โฆSee details»
Cell and gene therapy services | Xellera Therapeutics
At Xellera, we understand that the clinical and commercial success of cell and gene therapy products heavily hinges on the successful development of robust, reproducible, and scalable โฆSee details»
Xellera Therapeutics - Company Profile - Tracxn
Jul 11, 2024 Competitive landscape of Xellera Therapeutics Xellera Therapeutics ranks 1,340th among 2934 competitors which include Avidity Biosciences, Univercells and Sutro Biopharma. โฆSee details»
Our Technologies | CAR-T, iPSCs, MSCs | Xellera Therapeutics
A number of iPSC haplobank initiatives have been established around the world, including the US, Japan and Korea. Xellera has initiated the first iPSC haplobank project in Hong Kong in โฆSee details»
Newsroom | Updates and Announcements | Xellera Therapeutics
Feb 8, 2021 Get the latest news, events, and updates from Xellera Therapeutics on advancements in cell therapy and regenerative medicineSee details»